Clinical trial

Real World Data on Gi(l)Otrif® Dose Adjustment

NCT02751879

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-11-24

PhaseN/A

Study timeline

Study start (actual)2016-11-24Date precision: day

Registry last updated2019-08-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

ParisFrance2 SingaporeSingapore2 MadridSpain1 CharlotteNorth Carolina, United States1 The BronxNew York, United States1 VancouverBritish Columbia, Canada1 ViennaAustria1 TaichungTaiwan1 PoznanPoland1 EssenGermany1 DijonFrance1 BydgoszczPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02751879 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.